YAYuslinda Annisa

Yuslinda Annisa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuslinda Annisa has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrative Phytochemical and Computational Study of Curcuma aeruginosa as a Natural PI3K/AKT-1 Inhibitor Against HCC

    by Elvina Rashida Khairi, Muhammad Hermawan Widyananda, Dinia Rizqi Dwijayanti, Yuslinda Annisa, Siti Mariyah Ulfa, Nashi Widodo

    Curcuma aeruginosa RoxB., a medicinal plant known for its diverse pharmacological properties, has shown promising anticancer potential. In this context, the search for multitarget natural compounds remains a key strategy for developing safer and more effective therapies for hepatocellular carcinoma (HCC). Therefore, this study aimed to characterise the phytochemical composition of C. aeruginosa ethanolic extract and its fractions, and to investigate their potential molecular mechanisms against HCC through in silico approaches. Phytochemical quantification revealed that the ethanolic extract contained high levels of phenolic compounds, consistent with the LC-HRMS detection of phenol and phenylpropanoid derivatives. Conversely, the low total terpenoid content may be due to the use of linalool as a single standard, as the LC-HRMS results indicated abundant terpenoid constituents. Drug-likeness and bioactivity screening of the identified compounds revealed eight candidates with potential anticancer properties, including PTOX, 4’-demethylepipodophyllotoxin, dehydrocostus lactone, tretinoin, and vitamin A. Network and molecular docking analysis indicated that these compounds primarily target proteins involved in apoptosis and cancer-related pathways, particularly PI3K and AKT1. Molecular dynamics simulations confirmed the stability of the selected protein-ligand complexes, with PTOX and 4’-demethylepipodophyllotoxin showing the most favourable interactions with both target proteins. Collectively, these findings highlight C. aeruginosa, especially its crude ethanol extract, as a potential source of multitarget natural inhibitors against PI3K and AKT1, supporting its potential role as a promising candidate for the development of natural-based anti-HCC agents.

  • Open Access

    A novel pharmacological insight on Blumea balsamifera : profiling bioactive compounds and computational exploration of anti-breast cancer activity

    by Shella Zahra Kumala Azmi, Rayhan Yugo Nurul Maulana, Muhammad Hermawan Widyananda, Yuslinda Anissa, Elvina Rashida Khairi, Feri Eko Hermanto, Dinia Rizqi Dwijayanti, Sri Rahayu, Muhammad Sasmito Djati, Nashi Widodo

    Blumea balsamifera (L.) DC., locally known as ‘sembung legi’ in Indonesia, is a medicinal plant that is distributed across tropical and subtropical regions in Asia, including Southeast Asia [1]. Tr...

  • Open Access

    Extract of Holothuria scabra exhibits synergistic effect with chemotherapeutic agents against breast cancer in vitro

    by Teresa Liliana Wargasetia, Laella Kinghua Liana, Nashi Widodo, Yuslinda Annisa, Feri Eko Hermanto

    Context: Sea cucumbers have been identified as highly potential contenders in the fight against breast cancer. Aims: To investigate the potential of Holothuria scabra extract for anticancer against breast cancer cells in vitro by investigating its synergistic effects when integrated with frequently used chemotherapeutic medications. Methods: The Combenefit software was employed to assess the human breast cancer cell line T47D viability towards a synergistic combination of H. scabra extract and chemotherapeutic medications (cisplatin, doxorubicin, and neratinib). The investigation encompassed assessing the combination by utilizing a cell viability experiment employing a water-soluble tetrazolium-1 reagent. Subsequently, the selective cytotoxic effect was assessed by subjecting the highest cytotoxicity score to TIG-1-20 normal cells. Results: The synergistic model was evaluated by comparing interaction analysis through Loewe, Bliss, and Highest Single Agent (HSA) models. Combinations of H. scabra and Cisplatin showed synergistic activity with similar T47D cell viability values. However, the Loewe synergistic model had a higher T47D cell viability value, while the combination of H. scabra and neratinib had a higher T47D cell viability value. Moreover, co-administration of H. scabra and doxorubicin demonstrated notable efficacy in inhibiting the proliferation of T47D cells while exhibiting no cytotoxic effects on TIG-1-20 cells. Conclusions: Concurrent administration of H. scabra extract and doxorubicin exhibits promising synergistic properties in inhibiting the proliferation of T47D breast cancer cells while demonstrating no toxicity towards TIG-1-20 normal cells.


  • Open Access

    Encapsulated single garlic (Allium sativum L.) extract (E-SGE): A novel approach to inhibit adipogenesis in 3T3-L1 cells

    by Sri Rahayu Lestari, Suharti, Hendra Susanto, Putri Elok Septiana Dewi, Dimas Nur Ramadhani, Nenes Prastita, Dewi Sekar Miasih, Yuslinda Annisa, Alif Rosyidah El Baroroh

    Garlic (Allium sativum L.), a medicinal plant rich in bioactive compounds like allicin, ajoene, and alliin, is traditionally used to treat obesity and related disorders. However, its bioavailability is limited due to instability and poor solubility. To overcome these challenges, we encapsulated single garlic extract (SGE) in a chitosan-alginate matrix for enhancing stability and bioavailability. The morphological characteristics of the encapsulated particles were assessed via scanning electron microscopy (SEM), revealing them to be spherical, smooth, and porous. The cytotoxicity of encapsulated single garlic extract (E-SGE) was evaluated in 3T3-L1 cells using the MTT assay, and lipid accumulation during adipogenesis was monitored via Oil Red O (ORO) staining. Our results demonstrated that E-SGE significantly reduced lipid accumulation and inhibited adipogenesis in 3T3-L1 cells, as indicated by the decreased expression of adipogenic markers such as PPARγ, C/EBPα, GLUT4, and adiponectin. These findings suggest that E-SGE holds promise as a functional anti-obesity agent by targeting adipogenesis and enhancing the bioavailability of bioactive garlic compounds.


  • Characterization and In-vitro Study of Micro-encapsulation Chitosan Alginate of Single-bulb Garlic Extract

    by Sri Rahayu Lestari, Abdul Gofur, Dra. Hartatiek, Yuslinda Annisa, Dimas Nur Ramadhani, Amalia Nur Rahma, Dahniar Nur Aisyah, Ikfi Nihayatul Mufidah, Nadiya Dini Rifqi

    Background: Single-bulb garlic extract (SBGE) contains more active compounds than regular garlic, but it is unstable and easily degraded in the digestive tract. SBGE is expected to be protected by microencapsulation chitosan-alginate (MCA). Objective: The present study aimed to characterize and assess the antioxidant activity, hemocompatibility, and toxicity of MCA-SBGE in 3T3-L1 cells. Methods: The research procedures consist of extraction of single bulb garlic, preparation of MCASBGE, Particle Size Analyzer (PSA), FTIR analysis, DPPH assay, hemocompatibility test, and MTT assay. Results: The average size of MCA-SGBE was 423.7 ± 2.8 nm, the polydispersity index (PdI) was 0.446 ± 0.022, and the zeta potential was -24.5 ± 0.4 mV. MCA-SGBE was spherical with a diameter range of 0.65-0.9 μm. A shift in absorption and addition of functional groups was found in SBGE after encapsulation. MCA-SBGE, at a concentration of 24 x 103 ppm, has higher antioxidants than SBGE. The hemocompatibility test shows the hemolysis of MCA-SBGE lower than SBGE. MCA-SBGE was not toxic to 3T3-L1 cells with cell viability percentage above 100% at all concentrations. Conclusion: MCA-SBGE characterization has microparticle criteria with homogeneous PdI values, low particle stability, and spherical morphology. The results showed that SBGE and MCA-SBGE are nonhemolytic, compatible with red blood cells, and non-toxic to 3T3-L1 cells.


  • Open Access

    Black soybean tempeh and purple sweet potato improve sperm quality in streptozotocin-induced diabetic rats

    by Abdul Gofur, Agung Witjoro, Siti Nur Arifah, Mochammad Fitri Atho'ILlah, Yuslinda Annisa, Sri Rahayu Lestari

    Background and Aim: Hyperglycemia increases advanced glycation end-product (AGE) production, and the activity of receptor for AGE (RAGE) in testis, which leads to testicular histopathological damage and infertility. This research investigated the effect of black soybean tempeh (BST), purple sweet potato (PSP), and its combination on AGE and RAGE expression and spermatozoa quality in streptozotocin (STZ)-induced diabetic rats. Materials and Methods: The rats were given high-fat diets for 5 weeks, then were injected intraperitoneally with multiple low doses of STZ (30 mg/kg body weight). Diabetes mellitus (DM) rats were divided into seven groups: DM, DM+glibenclamide, DM+BST, DM+PSP, and DM+combination of BST and PSP in ratio 1:3, 2:2, and 3:1 as C1, C2, and C3, respectively. The rats were treated for 30 days. Testicular AGE and RAGE expression and spermatozoa quality were measured. Results: The combination of BST and PSP significantly decreased AGE and RAGE expression in testicular organs and improved spermatozoa quality compared to the normal group. Conclusion: The combination of BST and PSP can be used as future alternatives to improve spermatozoa quality in DM patients.